These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22041602)

  • 1. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
    Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface charge.
    Velpula A; Jukanti R; Janga KY; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Drug Dev Ind Pharm; 2013 Dec; 39(12):1895-906. PubMed ID: 22458264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ absorption and relative bioavailability studies of zaleplon loaded self-nanoemulsifying powders.
    Janga KY; Jukanti R; Sunkavalli S; Velpula A; Bandari S; Kandadi P; Veerareddy PR
    J Microencapsul; 2013; 30(2):161-72. PubMed ID: 22894164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.
    Bobbala SK; Veerareddy PR
    J Liposome Res; 2012 Dec; 22(4):285-94. PubMed ID: 22762199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia.
    Hosny KM; Banjar ZM
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1033-41. PubMed ID: 23795561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients.
    Khalifa MKA; Salem HA; Shawky SM; Eassa HA; Elaidy AM
    Drug Deliv; 2019 Dec; 26(1):1243-1253. PubMed ID: 31752566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability.
    Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS
    Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
    Nekkanti V; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleic acid derivative of polyethylenimine-functionalized proliposomes for enhancing oral bioavailability of extract of Ginkgo biloba.
    Zheng B; Yang S; Fan C; Bi Y; Du L; Zhao L; Lee RJ; Teng L; Teng L; Xie J
    Drug Deliv; 2016 May; 23(4):1194-203. PubMed ID: 26635185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery.
    Jukanti R; Sheela S; Bandari S; Veerareddy PR
    J Pharm Sci; 2011 Aug; 100(8):3208-3222. PubMed ID: 21404279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    AAPS PharmSciTech; 2016 Oct; 17(5):1019-29. PubMed ID: 26729532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses.
    Abd-Elrasheed E; El-Helaly SN; El-Ashmoony MM; Salah S
    Curr Drug Deliv; 2018; 15(6):898-906. PubMed ID: 29189154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
    Arregui JR; Kovvasu SP; Betageri GV
    AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.
    Hiremath PS; Soppimath KS; Betageri GV
    Int J Pharm; 2009 Oct; 380(1-2):96-104. PubMed ID: 19616608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats.
    Zheng B; Teng L; Xing G; Bi Y; Yang S; Hao F; Yan G; Wang X; Lee RJ; Teng L; Xie J
    Eur J Pharm Sci; 2015 Sep; 77():254-64. PubMed ID: 26116277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.